Intuitive Surgical: FY26 Q2 earnings call, Jul 16, 2026

Thu, Jul 16Earnings callSpeaker-labelled transcriptIntuitive Surgical

No Kalshi or Polymarket word markets were listed for Intuitive Surgical’s Jul 16, 2026 earnings call (FY26 Q2). The transcript is searchable below (quotes of at most 25 words).

Updated

Transcript

quotes of at most 25 words

Speaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.

3 matches for “FDA”; 3 quoted, at least 25 words apart.

David Rosacompanyprepared · 5:39Hear it 5:35, David Rosa

…training, and care team workflow. We have also submitted multiple innovations for FDA 510(k) clearance that leverage these updates. In line with our strategy, we…

David Rosacompanyprepared · 9:01Hear it 8:59, David Rosa

Recently, we submitted for FDA 510 clearance, a foundational non-commercial next-generation flexible robotic endoscope system for use in the gastrointestinal tract. We look forward to…

Rick Wiseanalystqa · 40:32Hear it 40:31, Rick Wise

…going to unfold and happen and roll out? I know subject to FDA approval, but how do we think about these incremental adds? Are there…

Agents: this page as TSV at /api/v1/appearances/intuitive-surgical:2026-07-16:earnings_call · words: /api/v1/brief?appearance=intuitive-surgical:2026-07-16:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP